17:03 EDT Biodexa Pharmaceuticals (BDRX) files $100M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Biodexa Pharmaceuticals Advances Serenta Trial and Secures Financial Backing
- Biodexa says requirement for financing represents ‘material uncertainty’
- Biodexa Pharmaceuticals reports 1H EPS (GBP0.0002) vs. (GBP0.001) last year
- Biodexa Pharmaceuticals Begins Phase 3 Trial for FAP Treatment
- Biodexa announces enrollment of first two patients in Phase 3 Serenta trial